Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Polatuzumab Vedotin

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ASH: Roche offers glimpse at Columvi-Polivy combo in DLBCL
    ASH: Roche offers glimpse at Columvi-Polivy combo in DLBCL

    11 Dec 2023

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma/roche-offers-glimpse-columvi-polivy-combos-early-data-untreated-dlbcl-ph3-kicks

    Angus Liu FIERCE PHARMA
    11 Dec 2023
    Share Share
    After approval in DLBCL, debate continues around benefit from Roche's ADC Polivy
    After approval in DLBCL, debate continues around benefit from Roche's ADC Polivy

    24 Aug 2023

    // Lei Lei Wu ENDPTS

    https://endpts.com/after-first-line-approval-in-dlbcl-debate-continues-around-benefit-from-roches-adc-polivy/

    Lei Lei Wu ENDPTS
    24 Aug 2023
    Share Share
    Roche guilty of serious marketing breach for Polivy website
    Roche guilty of serious marketing breach for Polivy website

    14 Jul 2023

    // Ben Adams FIERCE PHARMA

    https://www.fiercepharma.com/marketing/roche-mirroring-novartis-guilty-most-serious-marketing-breach-polivy-website

    Ben Adams FIERCE PHARMA
    14 Jul 2023
    Share Share
    Roche wins hard-fought approval for Polivy in earlier lymphoma
    Roche wins hard-fought approval for Polivy in earlier lymphoma

    20 Apr 2023

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma/roche-wins-hard-fought-fda-approval-polivy-changing-20-years-lymphoma-practice

    Angus Liu FIERCE PHARMA
    20 Apr 2023
    Share Share
    FDA adcomm votes 11-2 to expand Roche's Polivy label in DLBCL
    FDA adcomm votes 11-2 to expand Roche's Polivy label in DLBCL

    10 Mar 2023

    // Paul Schloesser ENDPTS

    https://endpts.com/fda-adcomm-votes-11-2-to-expand-roches-polivy-label-in-dlbcl/

    Paul Schloesser ENDPTS
    10 Mar 2023
    Share Share
    FDA raises questions in adcomm briefing docs for Roche's Polivy label expansion
    FDA raises questions in adcomm briefing docs for Roche's Polivy label expansion

    09 Mar 2023

    // Paul Schloesser ENDPTS

    https://endpts.com/fda-raises-questions-in-adcomm-briefing-docs-for-roches-polivy-label-expansion/

    Paul Schloesser ENDPTS
    09 Mar 2023
    Share Share